<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2020-10-07" version="218">
<accession>Q06787</accession>
<accession>A6NNH4</accession>
<accession>D3DWT0</accession>
<accession>D3DWT1</accession>
<accession>D3DWT2</accession>
<accession>G8JL90</accession>
<accession>Q16578</accession>
<accession>Q5PQZ6</accession>
<accession>Q99054</accession>
<name>FMR1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="84">Synaptic functional regulator FMR1</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="85">Fragile X mental retardation protein 1</fullName>
<shortName evidence="83">FMRP</shortName>
<shortName evidence="80">Protein FMR-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="85">FMR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="65" first="905" last="914">
<title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.</title>
<authorList>
<person name="Verkerk A.J.M.H."/>
<person name="Pieretti M."/>
<person name="Sutcliffe J.S."/>
<person name="Fu Y.H."/>
<person name="Kuhl D.P."/>
<person name="Pizzuti A."/>
<person name="Reiner O."/>
<person name="Richards S."/>
<person name="Victoria M.F."/>
<person name="Zhang F."/>
<person name="Eussen B.E."/>
<person name="van Ommen G.-J.B."/>
<person name="Blonden L.A.J."/>
<person name="Riggins G.J."/>
<person name="Chastain J.L."/>
<person name="Kunst C.B."/>
<person name="Galjaard H."/>
<person name="Caskey C.T."/>
<person name="Nelson D.L."/>
<person name="Oostra B.A."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="1710175"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90397-h"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="399" last="404">
<title>Alternative splicing in the fragile X gene FMR1.</title>
<authorList>
<person name="Verkerk A.J.M.H."/>
<person name="de Graaff E."/>
<person name="de Boulle K."/>
<person name="Eichler E.E."/>
<person name="Konecki D.S."/>
<person name="Reyniers E."/>
<person name="Manca A."/>
<person name="Poustka A."/>
<person name="Willems P.J."/>
<person name="Nelson D.L."/>
<person name="Oostra B.A."/>
</authorList>
<dbReference type="PubMed" id="8504300"/>
<dbReference type="DOI" id="10.1093/hmg/2.4.399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal brain</tissue>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1348" last="1348">
<authorList>
<person name="Verkerk A.J.H.M."/>
<person name="de Graaff E."/>
<person name="de Boulle K."/>
<person name="Eichler E.E."/>
<person name="Konecki D.S."/>
<person name="Reyniers E."/>
<person name="Manca A."/>
<person name="Poustka A."/>
<person name="Willems P.J."/>
<person name="Nelson D.L."/>
<person name="Oostra B.A."/>
</authorList>
<dbReference type="PubMed" id="8401531"/>
<dbReference type="DOI" id="10.1093/hmg/2.8.1348"/>
</citation>
<scope>ERRATUM OF PUBMED:8504300</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="3650" last="3650">
<title>Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.</title>
<authorList>
<person name="Corominas R."/>
<person name="Yang X."/>
<person name="Lin G.N."/>
<person name="Kang S."/>
<person name="Shen Y."/>
<person name="Ghamsari L."/>
<person name="Broly M."/>
<person name="Rodriguez M."/>
<person name="Tam S."/>
<person name="Wanamaker S.A."/>
<person name="Fan C."/>
<person name="Yi S."/>
<person name="Tasan M."/>
<person name="Lemmens I."/>
<person name="Kuang X."/>
<person name="Zhao N."/>
<person name="Malhotra D."/>
<person name="Michaelson J.J."/>
<person name="Vacic V."/>
<person name="Calderwood M.A."/>
<person name="Roth F.P."/>
<person name="Tavernier J."/>
<person name="Horvath S."/>
<person name="Salehi-Ashtiani K."/>
<person name="Korkin D."/>
<person name="Sebat J."/>
<person name="Hill D.E."/>
<person name="Hao T."/>
<person name="Vidal M."/>
<person name="Iakoucheva L.M."/>
</authorList>
<dbReference type="PubMed" id="24722188"/>
<dbReference type="DOI" id="10.1038/ncomms4650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9)</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1147" last="1153">
<title>Fine structure of the human FMR1 gene.</title>
<authorList>
<person name="Eichler E.E."/>
<person name="Richards S."/>
<person name="Gibbs R.A."/>
<person name="Nelson D.L."/>
</authorList>
<dbReference type="PubMed" id="8401496"/>
<dbReference type="DOI" id="10.1093/hmg/2.8.1147"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34; 36-139; 141-293; 295-490 AND 492-632</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="684" last="685">
<authorList>
<person name="Eichler E.E."/>
<person name="Richards S."/>
<person name="Gibbs R.A."/>
<person name="Nelson D.L."/>
</authorList>
<dbReference type="PubMed" id="8069329"/>
</citation>
<scope>ERRATUM OF PUBMED:8401496</scope>
</reference>
<reference key="10">
<citation type="submission" date="2006-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Eichler E.E."/>
<person name="Richards S."/>
<person name="Gibbs R.A."/>
<person name="Nelson D.L."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 18-34</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="56" first="67" last="74">
<title>Two new cases of FMR1 deletion associated with mental impairment.</title>
<authorList>
<person name="Hirst M."/>
<person name="Grewal P."/>
<person name="Flannery A."/>
<person name="Slatter R."/>
<person name="Maher E."/>
<person name="Barton D."/>
<person name="Fryns J.-P."/>
<person name="Davies K."/>
</authorList>
<dbReference type="PubMed" id="7825604"/>
<dbReference type="DOI" id="10.1002/ajmg.1320560115"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-17</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1993" name="Cell" volume="74" first="291" last="298">
<title>The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.</title>
<authorList>
<person name="Siomi H."/>
<person name="Siomi M.C."/>
<person name="Nussbaum R.L."/>
<person name="Dreyfuss G."/>
</authorList>
<dbReference type="PubMed" id="7688265"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90420-u"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>INVOLVEMENT IN FXS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="Nature" volume="363" first="722" last="724">
<title>Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.</title>
<authorList>
<person name="Verheij C."/>
<person name="Bakker C.E."/>
<person name="de Graaff E."/>
<person name="Keulemans J."/>
<person name="Willemsen R."/>
<person name="Verkerk A.J.M.H."/>
<person name="Galjaard H."/>
<person name="Reuser A.J.J."/>
<person name="Hoogeveen A.T."/>
<person name="Oostra B.A."/>
</authorList>
<dbReference type="PubMed" id="8515814"/>
<dbReference type="DOI" id="10.1038/363722a0"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="Nat. Genet." volume="4" first="335" last="340">
<title>The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.</title>
<authorList>
<person name="Devys D."/>
<person name="Lutz Y."/>
<person name="Rouyer N."/>
<person name="Bellocq J.-P."/>
<person name="Mandel J.-L."/>
</authorList>
<dbReference type="PubMed" id="8401578"/>
<dbReference type="DOI" id="10.1038/ng0893-335"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INVOLVEMENT IN FXS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Science" volume="262" first="563" last="566">
<title>FMR1 protein: conserved RNP family domains and selective RNA binding.</title>
<authorList>
<person name="Ashley C.T. Jr."/>
<person name="Wilkinson K.D."/>
<person name="Reines D."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="7692601"/>
<dbReference type="DOI" id="10.1126/science.7692601"/>
</citation>
<scope>ASSOCIATION IN MRNP</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="2401" last="2408">
<title>FXR1, an autosomal homolog of the fragile X mental retardation gene.</title>
<authorList>
<person name="Siomi M.C."/>
<person name="Siomi H."/>
<person name="Sauer W.H."/>
<person name="Srinivasan S."/>
<person name="Nussbaum R.L."/>
<person name="Dreyfuss G."/>
</authorList>
<dbReference type="PubMed" id="7781595"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1995.tb07237.x"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="5358" last="5366">
<title>The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.</title>
<authorList>
<person name="Zhang Y."/>
<person name="O'Connor J.P."/>
<person name="Siomi M.C."/>
<person name="Srinivasan S."/>
<person name="Dutra A."/>
<person name="Nussbaum R.L."/>
<person name="Dreyfuss G."/>
</authorList>
<dbReference type="PubMed" id="7489725"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1995.tb00220.x"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="95" last="102">
<title>Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms.</title>
<authorList>
<person name="Sittler A."/>
<person name="Devys D."/>
<person name="Weber C."/>
<person name="Mandel J.L."/>
</authorList>
<dbReference type="PubMed" id="8789445"/>
<dbReference type="DOI" id="10.1093/hmg/5.1.95"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS 6; 9; 10 AND 11)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 6; 9; 10 AND 11)</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="3825" last="3832">
<title>Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.</title>
<authorList>
<person name="Siomi M.C."/>
<person name="Zhang Y."/>
<person name="Siomi H."/>
<person name="Dreyfuss G."/>
</authorList>
<dbReference type="PubMed" id="8668200"/>
<dbReference type="DOI" id="10.1128/mcb.16.7.3825"/>
</citation>
<scope>INTERACTION WITH FXR1 AND FXR2</scope>
<scope>ASSOCIATION WITH RIBOSOMES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="Mol. Cell" volume="1" first="109" last="118">
<title>FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association.</title>
<authorList>
<person name="Feng Y."/>
<person name="Absher D."/>
<person name="Eberhart D.E."/>
<person name="Brown V."/>
<person name="Malter H.E."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="9659908"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80012-x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH POLYRIBOSOME AND MRNP</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="J. Med. Genet." volume="35" first="637" last="640">
<title>Studies of FRAXA and FRAXE in women with premature ovarian failure.</title>
<authorList>
<person name="Murray A."/>
<person name="Webb J."/>
<person name="Grimley S."/>
<person name="Conway G."/>
<person name="Jacobs P."/>
</authorList>
<dbReference type="PubMed" id="9719368"/>
<dbReference type="DOI" id="10.1136/jmg.35.8.637"/>
</citation>
<scope>INVOLVEMENT IN POF1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="863" last="869">
<title>Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.</title>
<authorList>
<person name="Tamanini F."/>
<person name="Bontekoe C."/>
<person name="Bakker C.E."/>
<person name="van Unen L."/>
<person name="Anar B."/>
<person name="Willemsen R."/>
<person name="Yoshida M."/>
<person name="Galjaard H."/>
<person name="Oostra B.A."/>
<person name="Hoogeveen A.T."/>
</authorList>
<dbReference type="PubMed" id="10196376"/>
<dbReference type="DOI" id="10.1093/hmg/8.5.863"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEOCYTOPLASMIC SHUTTLING</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="2557" last="2566">
<title>A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein.</title>
<authorList>
<person name="Bardoni B."/>
<person name="Schenck A."/>
<person name="Mandel J.-L."/>
</authorList>
<dbReference type="PubMed" id="10556305"/>
<dbReference type="DOI" id="10.1093/hmg/8.13.2557"/>
</citation>
<scope>INTERACTION WITH NUFIP1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="Cell" volume="107" first="477" last="487">
<title>Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.</title>
<authorList>
<person name="Brown V."/>
<person name="Jin P."/>
<person name="Ceman S."/>
<person name="Darnell J.C."/>
<person name="O'Donnell W.T."/>
<person name="Tenenbaum S.A."/>
<person name="Jin X."/>
<person name="Feng Y."/>
<person name="Wilkinson K.D."/>
<person name="Keene J.D."/>
<person name="Darnell R.B."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="11719188"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00568-2"/>
</citation>
<scope>ASSOCIATION WITH POLYRIBOSOME</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Cell" volume="107" first="489" last="499">
<title>Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function.</title>
<authorList>
<person name="Darnell J.C."/>
<person name="Jensen K.B."/>
<person name="Jin P."/>
<person name="Brown V."/>
<person name="Warren S.T."/>
<person name="Darnell R.B."/>
</authorList>
<dbReference type="PubMed" id="11719189"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00566-9"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="4803" last="4813">
<title>The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.</title>
<authorList>
<person name="Schaeffer C."/>
<person name="Bardoni B."/>
<person name="Mandel J.L."/>
<person name="Ehresmann B."/>
<person name="Ehresmann C."/>
<person name="Moine H."/>
</authorList>
<dbReference type="PubMed" id="11532944"/>
<dbReference type="DOI" id="10.1093/emboj/20.17.4803"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="329" last="338">
<title>Evidence that fragile X mental retardation protein is a negative regulator of translation.</title>
<authorList>
<person name="Laggerbauer B."/>
<person name="Ostareck D."/>
<person name="Keidel E.M."/>
<person name="Ostareck-Lederer A."/>
<person name="Fischer U."/>
</authorList>
<dbReference type="PubMed" id="11157796"/>
<dbReference type="DOI" id="10.1093/hmg/10.4.329"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FXR1 AND FXR2</scope>
<scope>SUBUNIT</scope>
<scope>RNA-BINDING</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="8332" last="8341">
<title>Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.</title>
<authorList>
<person name="De Diego Otero Y."/>
<person name="Severijnen L.A."/>
<person name="van Cappellen G."/>
<person name="Schrier M."/>
<person name="Oostra B."/>
<person name="Willemsen R."/>
</authorList>
<dbReference type="PubMed" id="12417734"/>
<dbReference type="DOI" id="10.1128/mcb.22.23.8332-8341.2002"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="8438" last="8447">
<title>Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties.</title>
<authorList>
<person name="Siomi M.C."/>
<person name="Higashijima K."/>
<person name="Ishizuka A."/>
<person name="Siomi H."/>
</authorList>
<dbReference type="PubMed" id="12446764"/>
<dbReference type="DOI" id="10.1128/mcb.22.24.8438-8447.2002"/>
</citation>
<scope>PHOSPHORYLATION AT SER-500</scope>
<scope>MUTAGENESIS OF SER-500</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="10437" last="10444">
<title>The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.</title>
<authorList>
<person name="Adinolfi S."/>
<person name="Ramos A."/>
<person name="Martin S.R."/>
<person name="Dal Piaz F."/>
<person name="Pucci P."/>
<person name="Bardoni B."/>
<person name="Mandel J.L."/>
<person name="Pastore A."/>
</authorList>
<dbReference type="PubMed" id="12950170"/>
<dbReference type="DOI" id="10.1021/bi034909g"/>
</citation>
<scope>SUBUNIT</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1689" last="1698">
<title>82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization.</title>
<authorList>
<person name="Bardoni B."/>
<person name="Castets M."/>
<person name="Huot M.-E."/>
<person name="Schenck A."/>
<person name="Adinolfi S."/>
<person name="Corbin F."/>
<person name="Pastore A."/>
<person name="Khandjian E.W."/>
<person name="Mandel J.-L."/>
</authorList>
<dbReference type="PubMed" id="12837692"/>
<dbReference type="DOI" id="10.1093/hmg/ddg181"/>
</citation>
<scope>INTERACTION WITH NUFIP2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="3087" last="3096">
<title>Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs.</title>
<authorList>
<person name="Mazroui R."/>
<person name="Huot M.E."/>
<person name="Tremblay S."/>
<person name="Boilard N."/>
<person name="Labelle Y."/>
<person name="Khandjian E.W."/>
</authorList>
<dbReference type="PubMed" id="14532325"/>
<dbReference type="DOI" id="10.1093/hmg/ddg335"/>
</citation>
<scope>INTERACTION WITH FXR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF SER-500</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="15669" last="15678">
<title>The fragile X mental retardation protein FMRP binds elongation factor 1A mRNA and negatively regulates its translation in vivo.</title>
<authorList>
<person name="Sung Y.J."/>
<person name="Dolzhanskaya N."/>
<person name="Nolin S.L."/>
<person name="Brown T."/>
<person name="Currie J.R."/>
<person name="Denman R.B."/>
</authorList>
<dbReference type="PubMed" id="12594214"/>
<dbReference type="DOI" id="10.1074/jbc.m211117200"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>ASSOCIATION WITH POLYRIBOSOME</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2003" name="Nature" volume="425" first="411" last="414">
<title>A micrococcal nuclease homologue in RNAi effector complexes.</title>
<authorList>
<person name="Caudy A.A."/>
<person name="Ketting R.F."/>
<person name="Hammond S.M."/>
<person name="Denli A.M."/>
<person name="Bathoorn A.M."/>
<person name="Tops B.B."/>
<person name="Silva J.M."/>
<person name="Myers M.M."/>
<person name="Hannon G.J."/>
<person name="Plasterk R.H."/>
</authorList>
<dbReference type="PubMed" id="14508492"/>
<dbReference type="DOI" id="10.1038/nature01956"/>
</citation>
<scope>INTERACTION WITH SND1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="Neuron" volume="37" first="417" last="431">
<title>RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.</title>
<authorList>
<person name="Miyashiro K.Y."/>
<person name="Beckel-Mitchener A."/>
<person name="Purk T.P."/>
<person name="Becker K.G."/>
<person name="Barret T."/>
<person name="Liu L."/>
<person name="Carbonetto S."/>
<person name="Weiler I.J."/>
<person name="Greenough W.T."/>
<person name="Eberwine J."/>
</authorList>
<dbReference type="PubMed" id="12575950"/>
<dbReference type="DOI" id="10.1016/s0896-6273(03)00034-5"/>
</citation>
<scope>FUNCTION</scope>
<scope>ASSOCIATION WITH MRNP</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2003" name="Neuroscience" volume="120" first="1005" last="1017">
<title>The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences.</title>
<authorList>
<person name="Chen L."/>
<person name="Yun S.W."/>
<person name="Seto J."/>
<person name="Liu W."/>
<person name="Toth M."/>
</authorList>
<dbReference type="PubMed" id="12927206"/>
<dbReference type="DOI" id="10.1016/s0306-4522(03)00406-8"/>
</citation>
<scope>RNA-BINDING</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="3346" last="3355">
<title>Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs.</title>
<authorList>
<person name="Rackham O."/>
<person name="Brown C.M."/>
</authorList>
<dbReference type="PubMed" id="15282548"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600341"/>
</citation>
<scope>INTERACTION WITH IGF2BP1</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="343" first="43" last="53">
<title>The C-terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.</title>
<authorList>
<person name="Menon R.P."/>
<person name="Gibson T.J."/>
<person name="Pastore A."/>
</authorList>
<dbReference type="PubMed" id="15381419"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.08.024"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH RANBP9</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2004" name="Nat. Neurosci." volume="7" first="113" last="117">
<title>Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.</title>
<authorList>
<person name="Jin P."/>
<person name="Zarnescu D.C."/>
<person name="Ceman S."/>
<person name="Nakamoto M."/>
<person name="Mowrey J."/>
<person name="Jongens T.A."/>
<person name="Nelson D.L."/>
<person name="Moses K."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="14703574"/>
<dbReference type="DOI" id="10.1038/nn1174"/>
</citation>
<scope>FUNCTION</scope>
<scope>ASSOCIATION WITH MICRORNA</scope>
<scope>INTERACTION WITH AGO2</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="FEBS Lett." volume="585" first="2556" last="2560">
<title>Evidence for the association of the human regulatory protein Ki-1/57 with the translational machinery.</title>
<authorList>
<person name="Goncalves K.A."/>
<person name="Bressan G.C."/>
<person name="Saito A."/>
<person name="Morello L.G."/>
<person name="Zanchin N.I."/>
<person name="Kobarg J."/>
</authorList>
<dbReference type="PubMed" id="21771594"/>
<dbReference type="DOI" id="10.1016/j.febslet.2011.07.010"/>
</citation>
<scope>INTERACTION WITH HABP4</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="903" last="918">
<title>Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes.</title>
<authorList>
<person name="Darnell J.C."/>
<person name="Fraser C.E."/>
<person name="Mostovetsky O."/>
<person name="Stefani G."/>
<person name="Jones T.A."/>
<person name="Eddy S.R."/>
<person name="Darnell R.B."/>
</authorList>
<dbReference type="PubMed" id="15805463"/>
<dbReference type="DOI" id="10.1101/gad.1276805"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2006" name="Biochemistry" volume="45" first="10385" last="10393">
<title>Alternative splicing modulates protein arginine methyltransferase-dependent methylation of fragile X syndrome mental retardation protein.</title>
<authorList>
<person name="Dolzhanskaya N."/>
<person name="Merz G."/>
<person name="Denman R.B."/>
</authorList>
<dbReference type="PubMed" id="16922515"/>
<dbReference type="DOI" id="10.1021/bi0525019"/>
</citation>
<scope>METHYLATION AT ARG-544</scope>
<scope>MUTAGENESIS OF ARG-544 AND ARG-546</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2006" name="Hum. Mol. Genet." volume="15" first="1525" last="1538">
<title>The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.</title>
<authorList>
<person name="Davidovic L."/>
<person name="Bechara E."/>
<person name="Gravel M."/>
<person name="Jaglin X.H."/>
<person name="Tremblay S."/>
<person name="Sik A."/>
<person name="Bardoni B."/>
<person name="Khandjian E.W."/>
</authorList>
<dbReference type="PubMed" id="16571602"/>
<dbReference type="DOI" id="10.1093/hmg/ddl074"/>
</citation>
<scope>INTERACTION WITH MCRS1</scope>
<scope>ASSOCIATION WITH POLYRIBOSOME</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-500</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="J. Biomed. Biotechnol." volume="2006" first="64347" last="64347">
<title>Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs.</title>
<authorList>
<person name="Plante I."/>
<person name="Davidovic L."/>
<person name="Ouellet D.L."/>
<person name="Gobeil L.A."/>
<person name="Tremblay S."/>
<person name="Khandjian E.W."/>
<person name="Provost P."/>
</authorList>
<dbReference type="PubMed" id="17057366"/>
<dbReference type="DOI" id="10.1155/jbb/2006/64347"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="1933" last="1946">
<title>Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP.</title>
<authorList>
<person name="Dolzhanskaya N."/>
<person name="Merz G."/>
<person name="Aletta J.M."/>
<person name="Denman R.B."/>
</authorList>
<dbReference type="PubMed" id="16636078"/>
<dbReference type="DOI" id="10.1242/jcs.02882"/>
</citation>
<scope>METHYLATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2006" name="Mol. Cell. Neurosci." volume="32" first="37" last="48">
<title>Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses.</title>
<authorList>
<person name="Antar L.N."/>
<person name="Li C."/>
<person name="Zhang H."/>
<person name="Carroll R.C."/>
<person name="Bassell G.J."/>
</authorList>
<dbReference type="PubMed" id="16631377"/>
<dbReference type="DOI" id="10.1016/j.mcn.2006.02.001"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="Nat. Neurosci." volume="10" first="578" last="587">
<title>A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability.</title>
<authorList>
<person name="Zalfa F."/>
<person name="Eleuteri B."/>
<person name="Dickson K.S."/>
<person name="Mercaldo V."/>
<person name="De Rubeis S."/>
<person name="di Penta A."/>
<person name="Tabolacci E."/>
<person name="Chiurazzi P."/>
<person name="Neri G."/>
<person name="Grant S.G."/>
<person name="Bagni C."/>
</authorList>
<dbReference type="PubMed" id="17417632"/>
<dbReference type="DOI" id="10.1038/nn1893"/>
</citation>
<scope>RNA-BINDING</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3055" last="3074">
<title>TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules.</title>
<authorList>
<person name="Goulet I."/>
<person name="Boisvenue S."/>
<person name="Mokas S."/>
<person name="Mazroui R."/>
<person name="Cote J."/>
</authorList>
<dbReference type="PubMed" id="18632687"/>
<dbReference type="DOI" id="10.1093/hmg/ddn203"/>
</citation>
<scope>INTERACTION WITH TDRD3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3236" last="3246">
<title>Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.</title>
<authorList>
<person name="Linder B."/>
<person name="Ploettner O."/>
<person name="Kroiss M."/>
<person name="Hartmann E."/>
<person name="Laggerbauer B."/>
<person name="Meister G."/>
<person name="Keidel E."/>
<person name="Fischer U."/>
</authorList>
<dbReference type="PubMed" id="18664458"/>
<dbReference type="DOI" id="10.1093/hmg/ddn219"/>
</citation>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH TDRD3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="5598" last="5610">
<title>In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein.</title>
<authorList>
<person name="Piazzon N."/>
<person name="Rage F."/>
<person name="Schlotter F."/>
<person name="Moine H."/>
<person name="Branlant C."/>
<person name="Massenet S."/>
</authorList>
<dbReference type="PubMed" id="18093976"/>
<dbReference type="DOI" id="10.1074/jbc.m707304200"/>
</citation>
<scope>INTERACTION WITH SMN</scope>
<scope>ASSOCIATION WITH THE SMN CORE COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="4902" last="4912">
<title>The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer.</title>
<authorList>
<person name="Didiot M.C."/>
<person name="Tian Z."/>
<person name="Schaeffer C."/>
<person name="Subramanian M."/>
<person name="Mandel J.L."/>
<person name="Moine H."/>
</authorList>
<dbReference type="PubMed" id="18653529"/>
<dbReference type="DOI" id="10.1093/nar/gkn472"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2008" name="RNA" volume="14" first="1644" last="1655">
<title>Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA.</title>
<authorList>
<person name="Menon L."/>
<person name="Mader S.A."/>
<person name="Mihailescu M.R."/>
</authorList>
<dbReference type="PubMed" id="18579868"/>
<dbReference type="DOI" id="10.1261/rna.1100708"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="4255" last="4266">
<title>Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein.</title>
<authorList>
<person name="Faehling M."/>
<person name="Mrowka R."/>
<person name="Steege A."/>
<person name="Kirschner K.M."/>
<person name="Benko E."/>
<person name="Foerstera B."/>
<person name="Persson P.B."/>
<person name="Thiele B.J."/>
<person name="Meier J.C."/>
<person name="Scholz H."/>
</authorList>
<dbReference type="PubMed" id="19097999"/>
<dbReference type="DOI" id="10.1074/jbc.m807354200"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>ASSOCIATION WITH POLYRIBOSOME AND MRNP</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="214" last="228">
<title>Fragile X mental retardation protein FMRP binds mRNAs in the nucleus.</title>
<authorList>
<person name="Kim M."/>
<person name="Bellini M."/>
<person name="Ceman S."/>
</authorList>
<dbReference type="PubMed" id="18936162"/>
<dbReference type="DOI" id="10.1128/mcb.01377-08"/>
</citation>
<scope>INTERACTION WITH NXF1</scope>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E16" last="E16">
<title>A novel function for fragile X mental retardation protein in translational activation.</title>
<authorList>
<person name="Bechara E.G."/>
<person name="Didiot M.C."/>
<person name="Melko M."/>
<person name="Davidovic L."/>
<person name="Bensaid M."/>
<person name="Martin P."/>
<person name="Castets M."/>
<person name="Pognonec P."/>
<person name="Khandjian E.W."/>
<person name="Moine H."/>
<person name="Bardoni B."/>
</authorList>
<dbReference type="PubMed" id="19166269"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000016"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="Nat. Neurosci." volume="13" first="819" last="821">
<title>Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack.</title>
<authorList>
<person name="Brown M.R."/>
<person name="Kronengold J."/>
<person name="Gazula V.R."/>
<person name="Chen Y."/>
<person name="Strumbos J.G."/>
<person name="Sigworth F.J."/>
<person name="Navaratnam D."/>
<person name="Kaczmarek L.K."/>
</authorList>
<dbReference type="PubMed" id="20512134"/>
<dbReference type="DOI" id="10.1038/nn.2563"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KCNT1</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2012" name="Nature" volume="492" first="382" last="386">
<title>FMRP targets distinct mRNA sequence elements to regulate protein expression.</title>
<authorList>
<person name="Ascano M. Jr."/>
<person name="Mukherjee N."/>
<person name="Bandaru P."/>
<person name="Miller J.B."/>
<person name="Nusbaum J.D."/>
<person name="Corcoran D.L."/>
<person name="Langlois C."/>
<person name="Munschauer M."/>
<person name="Dewell S."/>
<person name="Hafner M."/>
<person name="Williams Z."/>
<person name="Ohler U."/>
<person name="Tuschl T."/>
</authorList>
<dbReference type="PubMed" id="23235829"/>
<dbReference type="DOI" id="10.1038/nature11737"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="Mol. Cell. Neurosci." volume="56" first="333" last="341">
<title>FMRP and myelin protein expression in oligodendrocytes.</title>
<authorList>
<person name="Giampetruzzi A."/>
<person name="Carson J.H."/>
<person name="Barbarese E."/>
</authorList>
<dbReference type="PubMed" id="23891804"/>
<dbReference type="DOI" id="10.1016/j.mcn.2013.07.009"/>
</citation>
<scope>LACK OF FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="PLoS Genet." volume="9" first="E1003890" last="E1003890">
<title>Nuclear fragile X mental retardation protein is localized to Cajal bodies.</title>
<authorList>
<person name="Dury A.Y."/>
<person name="El Fatimy R."/>
<person name="Tremblay S."/>
<person name="Rose T.M."/>
<person name="Cote J."/>
<person name="De Koninck P."/>
<person name="Khandjian E.W."/>
</authorList>
<dbReference type="PubMed" id="24204304"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1003890"/>
</citation>
<scope>FUNCTION (ISOFORMS 6 AND 10)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 6; 9; 10 AND 11)</scope>
<scope>PROTEOLYTIC PROCESSING (ISOFORM 10)</scope>
<scope>RNA-BINDING (ISOFORMS 6 AND 10)</scope>
<scope>DOMAIN (ISOFORM 10)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304 (ISOFORM 10)</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2014" name="Cell" volume="157" first="869" last="881">
<title>A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.</title>
<authorList>
<person name="Alpatov R."/>
<person name="Lesch B.J."/>
<person name="Nakamoto-Kinoshita M."/>
<person name="Blanco A."/>
<person name="Chen S."/>
<person name="Stuetzer A."/>
<person name="Armache K.J."/>
<person name="Simon M.D."/>
<person name="Xu C."/>
<person name="Ali M."/>
<person name="Murn J."/>
<person name="Prisic S."/>
<person name="Kutateladze T.G."/>
<person name="Vakoc C.R."/>
<person name="Min J."/>
<person name="Kingston R.E."/>
<person name="Fischle W."/>
<person name="Warren S.T."/>
<person name="Page D.C."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="24813610"/>
<dbReference type="DOI" id="10.1016/j.cell.2014.03.040"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH METHYLATED HISTONE H3</scope>
<scope>DOMAIN</scope>
<scope>CHARACTERIZATION OF VARIANT FXS GLN-138</scope>
<scope>MUTAGENESIS OF THR-102 AND TYR-103</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2014" name="Cell Rep." volume="9" first="1729" last="1741">
<title>MOV10 and FMRP regulate AGO2 association with microRNA recognition elements.</title>
<authorList>
<person name="Kenny P.J."/>
<person name="Zhou H."/>
<person name="Kim M."/>
<person name="Skariah G."/>
<person name="Khetani R.S."/>
<person name="Drnevich J."/>
<person name="Arcila M.L."/>
<person name="Kosik K.S."/>
<person name="Ceman S."/>
</authorList>
<dbReference type="PubMed" id="25464849"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.10.054"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MOV10</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="3259" last="3259">
<title>Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virus.</title>
<authorList>
<person name="Zhou Z."/>
<person name="Cao M."/>
<person name="Guo Y."/>
<person name="Zhao L."/>
<person name="Wang J."/>
<person name="Jia X."/>
<person name="Li J."/>
<person name="Wang C."/>
<person name="Gabriel G."/>
<person name="Xue Q."/>
<person name="Yi Y."/>
<person name="Cui S."/>
<person name="Jin Q."/>
<person name="Wang J."/>
<person name="Deng T."/>
</authorList>
<dbReference type="PubMed" id="24514761"/>
<dbReference type="DOI" id="10.1038/ncomms4259"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH INFLUENZA A NP (MICROBIAL INFECTION)</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304 (MICROBIAL INFECTION)</scope>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E91465" last="E91465">
<title>Subcellular fractionation and localization studies reveal a direct interaction of the fragile X mental retardation protein (FMRP) with nucleolin.</title>
<authorList>
<person name="Taha M.S."/>
<person name="Nouri K."/>
<person name="Milroy L.G."/>
<person name="Moll J.M."/>
<person name="Herrmann C."/>
<person name="Brunsveld L."/>
<person name="Piekorz R.P."/>
<person name="Ahmadian M.R."/>
</authorList>
<dbReference type="PubMed" id="24658146"/>
<dbReference type="DOI" id="10.1371/journal.pone.0091465"/>
</citation>
<scope>INTERACTION WITH CYFIP2; EIF5; NCL AND RPLP0 (ISOFORM 6)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF 527-ARG--ARG-534 AND 613-GLN--LYS-617</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2014" name="RNA Biol." volume="11" first="1364" last="1374">
<title>FMRP interacts with G-quadruplex structures in the 3'-UTR of its dendritic target Shank1 mRNA.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Gaetano C.M."/>
<person name="Williams K.R."/>
<person name="Bassell G.J."/>
<person name="Mihailescu M.R."/>
</authorList>
<dbReference type="PubMed" id="25692235"/>
<dbReference type="DOI" id="10.1080/15476286.2014.996464"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF SER-500</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2016" name="PLoS Pathog." volume="12" first="E1005810" last="E1005810">
<title>New World and Old World Alphaviruses Have Evolved to Exploit Different Components of Stress Granules, FXR and G3BP Proteins, for Assembly of Viral Replication Complexes.</title>
<authorList>
<person name="Kim D.Y."/>
<person name="Reynaud J.M."/>
<person name="Rasalouskaya A."/>
<person name="Akhrymuk I."/>
<person name="Mobley J.A."/>
<person name="Frolov I."/>
<person name="Frolova E.I."/>
</authorList>
<dbReference type="PubMed" id="27509095"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1005810"/>
</citation>
<scope>INTERACTION WITH VENEZUELAN EQUINE ENCEPHALITIS VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1997" name="Nat. Struct. Biol." volume="4" first="712" last="716">
<title>The solution structure of the first KH domain of FMR1, the protein responsible for the fragile X syndrome.</title>
<authorList>
<person name="Musco G."/>
<person name="Kharrat A."/>
<person name="Stier G."/>
<person name="Fraternali F."/>
<person name="Gibson T.J."/>
<person name="Nilges M."/>
<person name="Pastore A."/>
</authorList>
<dbReference type="PubMed" id="9302998"/>
<dbReference type="DOI" id="10.1038/nsb0997-712"/>
</citation>
<scope>STRUCTURE BY NMR OF 216-280</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2006" name="Structure" volume="14" first="21" last="31">
<title>The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction.</title>
<authorList>
<person name="Ramos A."/>
<person name="Hollingworth D."/>
<person name="Adinolfi S."/>
<person name="Castets M."/>
<person name="Kelly G."/>
<person name="Frenkiel T.A."/>
<person name="Bardoni B."/>
<person name="Pastore A."/>
</authorList>
<dbReference type="PubMed" id="16407062"/>
<dbReference type="DOI" id="10.1016/j.str.2005.09.018"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-134</scope>
<scope>MUTAGENESIS OF 125-THR-PHE-126</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NUFIP2</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2007" name="Structure" volume="15" first="1090" last="1098">
<title>Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein.</title>
<authorList>
<person name="Valverde R."/>
<person name="Pozdnyakova I."/>
<person name="Kajander T."/>
<person name="Venkatraman J."/>
<person name="Regan L."/>
</authorList>
<dbReference type="PubMed" id="17850748"/>
<dbReference type="DOI" id="10.1016/j.str.2007.06.022"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 397-425</scope>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1993" name="Nat. Genet." volume="3" first="31" last="35">
<title>A point mutation in the FMR-1 gene associated with fragile X mental retardation.</title>
<authorList>
<person name="de Boulle K."/>
<person name="Verkerk A.J.M.H."/>
<person name="Reyniers E."/>
<person name="Vits L."/>
<person name="Hendrickx J."/>
<person name="van Roy B."/>
<person name="van den Bos F."/>
<person name="de Graaff E."/>
<person name="Oostra B.A."/>
<person name="Willems P.J."/>
</authorList>
<dbReference type="PubMed" id="8490650"/>
<dbReference type="DOI" id="10.1038/ng0193-31"/>
</citation>
<scope>VARIANT FXS ASN-304</scope>
</reference>
<reference key="75">
<citation type="journal article" date="1994" name="Cell" volume="77" first="33" last="39">
<title>Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.</title>
<authorList>
<person name="Siomi H."/>
<person name="Choi M."/>
<person name="Siomi M.C."/>
<person name="Nussbaum R.L."/>
<person name="Dreyfuss G."/>
</authorList>
<dbReference type="PubMed" id="8156595"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90232-1"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="895" last="901">
<title>Characterization of FMR1 proteins isolated from different tissues.</title>
<authorList>
<person name="Verheij C."/>
<person name="de Graaff E."/>
<person name="Bakker C.E."/>
<person name="Willemsen R."/>
<person name="Willems P.J."/>
<person name="Meijer N."/>
<person name="Galjaard H."/>
<person name="Reuser A.J.J."/>
<person name="Oostra B.A."/>
<person name="Hoogeveen A.T."/>
</authorList>
<dbReference type="PubMed" id="7633450"/>
<dbReference type="DOI" id="10.1093/hmg/4.5.895"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="10" first="393" last="399">
<title>Novel point mutation within intron 10 of FMR-1 gene causing fragile X syndrome.</title>
<authorList>
<person name="Wang Y.-C."/>
<person name="Lin M.-L."/>
<person name="Lin S.J."/>
<person name="Li Y.-C."/>
<person name="Li S.-Y."/>
</authorList>
<dbReference type="PubMed" id="9375856"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1997)10:5&lt;393::aid-humu10&gt;3.0.co;2-v"/>
</citation>
<scope>VARIANT HIS-546</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2001" name="Neurology" volume="57" first="127" last="130">
<title>Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.</title>
<authorList>
<person name="Hagerman R.J."/>
<person name="Leehey M."/>
<person name="Heinrichs W."/>
<person name="Tassone F."/>
<person name="Wilson R."/>
<person name="Hills J."/>
<person name="Grigsby J."/>
<person name="Gage B."/>
<person name="Hagerman P.J."/>
</authorList>
<dbReference type="PubMed" id="11445641"/>
<dbReference type="DOI" id="10.1212/wnl.57.1.127"/>
</citation>
<scope>INVOLVEMENT IN FXTAS</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2004" name="Exp. Neurol." volume="189" first="343" last="353">
<title>Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.</title>
<authorList>
<person name="Schrier M."/>
<person name="Severijnen L.A."/>
<person name="Reis S."/>
<person name="Rife M."/>
<person name="van't Padje S."/>
<person name="van Cappellen G."/>
<person name="Oostra B.A."/>
<person name="Willemsen R."/>
</authorList>
<dbReference type="PubMed" id="15380484"/>
<dbReference type="DOI" id="10.1016/j.expneurol.2004.05.039"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FXS ASN-304</scope>
<scope>INTERACTION WITH FXR1 AND RPLP0</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152" first="2512" last="2520">
<title>Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males.</title>
<authorList>
<person name="Collins S.C."/>
<person name="Bray S.M."/>
<person name="Suhl J.A."/>
<person name="Cutler D.J."/>
<person name="Coffee B."/>
<person name="Zwick M.E."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="20799337"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33626"/>
</citation>
<scope>VARIANT GLN-138</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2014" name="Eur. J. Hum. Genet." volume="22" first="1185" last="1189">
<title>Fragile X syndrome due to a missense mutation.</title>
<authorList>
<person name="Myrick L.K."/>
<person name="Nakamoto-Kinoshita M."/>
<person name="Lindor N.M."/>
<person name="Kirmani S."/>
<person name="Cheng X."/>
<person name="Warren S.T."/>
</authorList>
<dbReference type="PubMed" id="24448548"/>
<dbReference type="DOI" id="10.1038/ejhg.2013.311"/>
</citation>
<scope>VARIANT FXS GLU-266</scope>
<scope>CHARACTERIZATION OF VARIANT FXS GLU-266</scope>
<scope>RNA-BINDING</scope>
<scope>ASSOCIATION WITH POLYRIBOSOME</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="949" last="956">
<title>Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.</title>
<authorList>
<person name="Myrick L.K."/>
<person name="Deng P.Y."/>
<person name="Hashimoto H."/>
<person name="Oh Y.M."/>
<person name="Cho Y."/>
<person name="Poidevin M.J."/>
<person name="Suhl J.A."/>
<person name="Visootsak J."/>
<person name="Cavalli V."/>
<person name="Jin P."/>
<person name="Cheng X."/>
<person name="Warren S.T."/>
<person name="Klyachko V.A."/>
</authorList>
<dbReference type="PubMed" id="25561520"/>
<dbReference type="DOI" id="10.1073/pnas.1423094112"/>
</citation>
<scope>VARIANT FXS GLN-138</scope>
<scope>CHARACTERIZATION OF VARIANT FXS GLN-138</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KCNMB4</scope>
<scope>DOMAIN</scope>
</reference>
<comment type="function">
<text evidence="9 10 15 17 19 23 25 26 29 30 32 33 36 39 40 43 45 47 48 49 50 53 54 56 59 60 61 62 66 67 68 69">Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity through the regulation of alternative mRNA splicing, mRNA stability, mRNA dendritic transport and postsynaptic local protein synthesis of a subset of mRNAs (PubMed:16631377, PubMed:18653529, PubMed:19166269, PubMed:23235829, PubMed:25464849). Plays a role in the alternative splicing of its own mRNA (PubMed:18653529). Plays a role in mRNA nuclear export (By similarity). Together with export factor NXF2, is involved in the regulation of the NXF1 mRNA stability in neurons (By similarity). Stabilizes the scaffolding postsynaptic density protein DLG4/PSD-95 and the myelin basic protein (MBP) mRNAs in hippocampal neurons and glial cells, respectively; this stabilization is further increased in response to metabotropic glutamate receptor (mGluR) stimulation (By similarity). Plays a role in selective delivery of a subset of dendritic mRNAs to synaptic sites in response to mGluR activation in a kinesin-dependent manner (By similarity). Plays a role as a repressor of mRNA translation during the transport of dendritic mRNAs to postsynaptic dendritic spines (PubMed:11532944, PubMed:11157796, PubMed:12594214, PubMed:23235829). Component of the CYFIP1-EIF4E-FMR1 complex which blocks cap-dependent mRNA translation initiation (By similarity). Represses mRNA translation by stalling ribosomal translocation during elongation (By similarity). Reports are contradictory with regards to its ability to mediate translation inhibition of MBP mRNA in oligodendrocytes (PubMed:23891804). Also involved in the recruitment of the RNA helicase MOV10 to a subset of mRNAs and hence regulates microRNA (miRNA)-mediated translational repression by AGO2 (PubMed:14703574, PubMed:17057366, PubMed:25464849). Facilitates the assembly of miRNAs on specific target mRNAs (PubMed:17057366). Plays also a role as an activator of mRNA translation of a subset of dendritic mRNAs at synapses (PubMed:19097999, PubMed:19166269). In response to mGluR stimulation, FMR1-target mRNAs are rapidly derepressed, allowing for local translation at synapses (By similarity). Binds to a large subset of dendritic mRNAs that encode a myriad of proteins involved in pre- and postsynaptic functions (PubMed:7692601, PubMed:11719189, PubMed:11157796, PubMed:12594214, PubMed:17417632, PubMed:23235829, PubMed:24448548). Binds to 5'-ACU[GU]-3' and/or 5'-[AU]GGA-3' RNA consensus sequences within mRNA targets, mainly at coding sequence (CDS) and 3'-untranslated region (UTR) and less frequently at 5'-UTR (PubMed:23235829). Binds to intramolecular G-quadruplex structures in the 5'- or 3'-UTRs of mRNA targets (PubMed:11719189, PubMed:18579868, PubMed:25464849, PubMed:25692235). Binds to G-quadruplex structures in the 3'-UTR of its own mRNA (PubMed:7692601, PubMed:11532944, PubMed:12594214, PubMed:15282548, PubMed:18653529). Binds also to RNA ligands harboring a kissing complex (kc) structure; this binding may mediate the association of FMR1 with polyribosomes (PubMed:15805463). Binds mRNAs containing U-rich target sequences (PubMed:12927206). Binds to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the 5'-UTR region of superoxide dismutase SOD1 mRNA (PubMed:19166269). Binds to the dendritic, small non-coding brain cytoplasmic RNA 1 (BC1); which may increase the association of the CYFIP1-EIF4E-FMR1 complex to FMR1 target mRNAs at synapses (By similarity). Associates with export factor NXF1 mRNA-containing ribonucleoprotein particles (mRNPs) in a NXF2-dependent manner (By similarity). Binds to a subset of miRNAs in the brain (PubMed:14703574, PubMed:17057366). May associate with nascent transcripts in a nuclear protein NXF1-dependent manner (PubMed:18936162). In vitro, binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:7688265, PubMed:7781595, PubMed:12950170, PubMed:15381419, PubMed:8156595). Moreover, plays a role in the modulation of the sodium-activated potassium channel KCNT1 gating activity (PubMed:20512134). Negatively regulates the voltage-dependent calcium channel current density in soma and presynaptic terminals of dorsal root ganglion (DRG) neurons, and hence regulates synaptic vesicle exocytosis (By similarity). Modulates the voltage-dependent calcium channel CACNA1B expression at the plasma membrane by targeting the channels for proteosomal degradation (By similarity). Plays a role in regulation of MAP1B-dependent microtubule dynamics during neuronal development (By similarity). Recently, has been shown to play a translation-independent role in the modulation of presynaptic action potential (AP) duration and neurotransmitter release via large-conductance calcium-activated potassium (BK) channels in hippocampal and cortical excitatory neurons (PubMed:25561520). Finally, FMR1 may be involved in the control of DNA damage response (DDR) mechanisms through the regulation of ATR-dependent signaling pathways such as histone H2AX/H2A.x and BRCA1 phosphorylations (PubMed:24813610).</text>
</comment>
<comment type="function">
<molecule>Isoform 10</molecule>
<text evidence="55">binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:24204304). May bind to RNA in Cajal bodies (PubMed:24204304).</text>
</comment>
<comment type="function">
<molecule>Isoform 6</molecule>
<text evidence="55">binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:24204304). May bind to RNA in Cajal bodies (PubMed:24204304).</text>
</comment>
<comment type="function">
<text evidence="57">(Microbial infection) Acts as a positive regulator of influenza A virus (IAV) replication. Required for the assembly and nuclear export of the viral ribonucleoprotein (vRNP) components.</text>
</comment>
<comment type="subunit">
<text evidence="9 14 15 18 22 23 24 26 27 28 29 30 31 32 34 35 37 42 44 46 47 48 50 52 56 58 59 60 61 64 67 74 77">Homodimer (PubMed:7489725, PubMed:12950170, PubMed:16636078). Forms heterodimer with FXR1; heterodimerization occurs in a methylation-dependent manner (PubMed:7489725, PubMed:11157796, PubMed:16636078). Forms heterodimer with FXR2 (PubMed:7489725, PubMed:11157796). Homooligomer (PubMed:11157796, PubMed:18664458). Component of the CYFIP1-EIF4E-FMR1 complex at least composed of CYFIP, EIF4E and FMR1; this mRNA cap binding complex formation increases in presence of the brain cytoplasmic RNA BC1 and is dynamically regulated in an activity-dependent manner to repress and then possibly release dendritic mRNAs for translation in response to mGluR stimulation (By similarity). Associates with the SMN core complex that contains SMN, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8 and STRAP/UNRIP (PubMed:18093976). Part of a ribonucleoprotein complex with AGO2/EIF2C2 and miRNAs (PubMed:14703574). Interacts with AGO2/EIF2C2 (PubMed:14703574). Interacts (via C-terminus) with CACNA1B; this interaction induces a decrease in the number of presynaptic functional CACNA1B channels at the cell surface (By similarity). Interacts with CYFIP1; this interaction recruits CYFIP1 to capped mRNA (By similarity). Interacts with CYFIP2 (By similarity). Interacts with EIF5; this interaction occurs in a RNA-dependent manner (By similarity). Interacts with dynein (By similarity). Interacts with FXR1 and FXR2 (PubMed:8668200, PubMed:14532325, PubMed:15380484). Interacts with methylated histone H3 (PubMed:24813610). Interacts with IGF2BP1; this interaction allows to recruit IGF2BP1 to mRNA in a FMR1-dependent manner (PubMed:15282548). Interacts (via N-terminus) with KCNMB4 (PubMed:25561520). Interacts with KCNT1 (via C-terminus); this interaction alters gating properties of KCNT1 (PubMed:20512134). Interacts (via phosphorylated form) with MCRS1 (via N-terminus) (PubMed:16571602). Interacts with MOV10; this interaction is direct, occurs in an RNA-dependent manner on polysomes and induces association of MOV10 with RNAs (PubMed:25464849). Interacts with MYO5A and PURA; these interactions occur in association with polyribosome (By similarity). Interacts with NCL (By similarity). Interacts with NUFIP1 (PubMed:10556305). Interacts (via N-terminus) with NUFIP2 (PubMed:12837692, PubMed:16407062). Interacts with NXF1; this interaction occurs in a mRNA-dependent and polyribosome-independent manner in the nucleus (PubMed:18936162). Interacts with NXF2 (via N-terminus); this interaction is direct and occurs in a NXF1 mRNA-containing mRNP complexes (By similarity). Interacts with RANBP9 (via C-terminus); this interaction is direct and inhibits binding of FMR1 to RNA homopolymer (PubMed:15381419). Interacts with RPLP0 (PubMed:15380484). Interacts (via C-terminus) with SMN (via C-terminus); this interaction is direct and occurs in a RNA-independent manner (PubMed:18093976). Interacts with TDRD3 (via C-terminus); this interaction is direct (PubMed:18632687, PubMed:18664458). Interacts with YBX1; this interaction occurs in association with polyribosome (By similarity). Interacts with nucleosome (PubMed:24813610). Associates with polyribosome; this association occurs in a mRNA-dependent manner (PubMed:9659908, PubMed:11719188, PubMed:12594214, PubMed:19097999, PubMed:24448548). Associates with cytoplasmic messenger ribonucleoprotein particles (mRNPs) (PubMed:7692601, PubMed:9659908, PubMed:12575950, PubMed:19097999). Associates with microtubules in a kinesin- and dynein-dependent manner (By similarity). Isoform 6 interacts (via N-terminus) with NCL (via C-terminus) (PubMed:24658146). Isoform 6 interacts with CYFIP2; this interaction occurs in a RNA-dependent manner (PubMed:24658146). Isoform 6 interacts with EIF5; this interaction occurs in a RNA-dependent manner (PubMed:24658146). Isoform 6 interacts with RPLP0 (PubMed:24658146). Interacts with HABP4 (PubMed:21771594). Interacts with SND1 (PubMed:14508492).</text>
</comment>
<comment type="subunit">
<text evidence="57">(Microbial infection) Interacts (via KH 2 domain) with influenza A nucleoprotein (NP); this interaction occurs in a RNA-dependent manner and stimulates viral ribonucleoprotein (vRNP) assembly and subsequent RNA synthesis.</text>
</comment>
<comment type="subunit">
<text evidence="63">(Microbial infection) Interacts with Sindbis virus non-structural protein 3 (via C-terminus); this interaction inhibits the formation of host stress granules on viral mRNAs and the nsp3-FMR1 complexes bind viral RNAs and probably orchestrate the assembly of viral replication complexes.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366305">
<id>Q06787</id>
</interactant>
<interactant intactId="EBI-1048143">
<id>Q7L576</id>
<label>CYFIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366305">
<id>Q06787</id>
</interactant>
<interactant intactId="EBI-2433893">
<id>Q96F07</id>
<label>CYFIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366305">
<id>Q06787</id>
</interactant>
<interactant intactId="EBI-366305">
<id>Q06787</id>
<label>FMR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10224470">
<id>Q06787-8</id>
</interactant>
<interactant intactId="EBI-5661036">
<id>A1L4K1</id>
<label>FSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10224470">
<id>Q06787-8</id>
</interactant>
<interactant intactId="EBI-740459">
<id>P51116</id>
<label>FXR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 35 47">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24 34 35 58">Nucleus</location>
<location evidence="24 34 35 58">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Chromosome</location>
<location evidence="9">Centromere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 24 46 47 68 70 73">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="58">Cytoplasm</location>
<location evidence="58">Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20 28 31 37 42 77">Cytoplasm</location>
<location evidence="20 28 31 37 42 77">Cytoplasmic ribonucleoprotein granule</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20 31 42">Perikaryon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20 31 42">Cell projection</location>
<location evidence="20 31 42">Neuron projection</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Dendrite</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Dendritic spine</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell junction</location>
<location evidence="9">Synapse</location>
<location evidence="9">Synaptosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Cell projection</location>
<location evidence="31">Growth cone</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Filopodium tip</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell junction</location>
<location evidence="9">Synapse</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell junction</location>
<location evidence="9">Synapse</location>
<location evidence="9">Postsynaptic cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell junction</location>
<location evidence="9">Synapse</location>
<location evidence="9">Presynaptic cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="37 44 46">Cytoplasm</location>
<location evidence="37 44 46">Stress granule</location>
</subcellularLocation>
<text evidence="9 10 13 20 28 31 37 42 44 46 77">Colocalizes with H2AX/H2A.x in pericentromeric heterochromatin in response to DNA damaging agents (By similarity). Localizes on meiotic pachytene-stage chromosomes (By similarity). Forms nuclear foci representing sites of ongoing DNA replication in response to DNA damaging agents (By similarity). Shuttles between nucleus and cytoplasm in a XPO1/CRM1-dependent manner (PubMed:10196376). Localizes to cytoplasmic ribonucleoprotein granules, also referred to as messenger ribonucleoprotein particles or mRNPs, along dendrites and dendritic spines (PubMed:9659908, PubMed:14532325). FMR1-containing cytoplasmic granules colocalize to F-actin-rich structures, including filopodium, spines and growth cone during the development of hippocampal neurons (By similarity). FMR1-containing cytoplasmic granules are transported out of the soma along axon and dendrite to synaptic contacts in a microtubule- and kinesin-dependent manner (PubMed:12417734, PubMed:15380484). Colocalizes with CACNA1B in the cytoplasm and at the cell membrane of neurons (By similarity). Colocalizes with CYFIP1, CYFIP2, NXF2 and ribosomes in the perinuclear region (By similarity). Colocalizes with CYFIP1 and EIF4E in dendrites and probably at synapses (By similarity). Colocalizes with FXR1, kinesin, 60S acidic ribosomal protein RPLP0 and SMN in cytoplasmic granules in the soma and neurite cell processes (PubMed:12417734, PubMed:18093976, PubMed:16636078). Colocalizes with FXR1 and FXR2 in discrete granules, called fragile X granules (FXGs), along axon and presynaptic compartments (By similarity). Colocalizes with TDRD3 in cytoplasmic stress granules (SGs) in response to various cellular stress (PubMed:18632687, PubMed:18664458, PubMed:16636078).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 6</molecule>
<subcellularLocation>
<location evidence="55 75">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="55">Cytoplasm</location>
<location evidence="55">Perinuclear region</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 9</molecule>
<subcellularLocation>
<location evidence="55 75">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 10</molecule>
<subcellularLocation>
<location evidence="75">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="55">Nucleus</location>
<location evidence="55">Cajal body</location>
</subcellularLocation>
<text>Colocalizes with Colin and SMN in Cajal bodies (PubMed:24204304).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 11</molecule>
<subcellularLocation>
<location evidence="75">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="55">Nucleus</location>
<location evidence="55">Cajal body</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q06787-1</id>
<name>6</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q06787-2</id>
<name>1</name>
<sequence type="described" ref="VSP_002823 VSP_002826"/>
</isoform>
<isoform>
<id>Q06787-3</id>
<name>2</name>
<sequence type="described" ref="VSP_002824"/>
</isoform>
<isoform>
<id>Q06787-4</id>
<name>3</name>
<sequence type="described" ref="VSP_002824 VSP_002826"/>
</isoform>
<isoform>
<id>Q06787-5</id>
<name>4</name>
<sequence type="described" ref="VSP_002825"/>
</isoform>
<isoform>
<id>Q06787-6</id>
<name>5</name>
<sequence type="described" ref="VSP_002825 VSP_002826"/>
</isoform>
<isoform>
<id>Q06787-7</id>
<name>7</name>
<sequence type="described" ref="VSP_002826"/>
</isoform>
<isoform>
<id>Q06787-8</id>
<name>8</name>
<sequence type="described" ref="VSP_002823 VSP_002825"/>
</isoform>
<isoform>
<id>Q06787-9</id>
<name>9</name>
<name>B</name>
<sequence type="described" ref="VSP_002823"/>
</isoform>
<isoform>
<id>Q06787-10</id>
<name>10</name>
<name evidence="82">ISO6</name>
<sequence type="described" ref="VSP_058423"/>
</isoform>
<isoform>
<id>Q06787-11</id>
<name>11</name>
<name evidence="82">ISO12</name>
<sequence type="described" ref="VSP_002823 VSP_058423"/>
</isoform>
<text>At least 12 different isoforms are produced.</text>
</comment>
<comment type="tissue specificity">
<text evidence="54 55 70 72">Expressed in the brain, cerebellum and testis (PubMed:8401578). Also expressed in epithelial tissues (PubMed:8401578). Expressed in mature oligodendrocytes (OLGs) (PubMed:23891804). Expressed in fibroblast (PubMed:24204304). Expressed in neurons, Purkinje cells and spermatogonias (at protein level) (PubMed:8401578). Expressed in brain, testis and placenta (PubMed:8504300). Expressed in neurons and lymphocytes (PubMed:8504300).</text>
</comment>
<comment type="induction">
<text evidence="57">(Microbial infection) Up-regulated in response to infection by influenza A virus.</text>
</comment>
<comment type="domain">
<text evidence="17 19 26 28 33 39 43 49 59 61 62">The N-terminal 134 amino acids are necessary for homodimerization and RNA-binding (PubMed:12950170). The N-terminal 298 amino acids are sufficient to interact with KCNMB4 and to regulate presynaptic action potential (AP) duration in neurons (PubMed:25561520). The two agenet-like domains are necessary for binding to histone H3 in a methylation-dependent manner (PubMed:24813610). The KH domains are necessary for mediating miRNA annealing to specific RNA targets (PubMed:17057366). The KH 2 domain is necessary for binding to kissing complex (kc) RNA ligands (PubMed:15805463). The RGG box domain is necessary for binding to mRNA targets that contain G-quadruplex structures (PubMed:11719189, PubMed:18579868, PubMed:25692235). The RGG-box domain is necessary for binding to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the superoxide dismutase SOD1 mRNA (PubMed:19166269). The RGG box domain is necessary for binding to its own mRNA (PubMed:11532944). The RGG-box domain is necessary for binding to homopolymer poly(G) (PubMed:14532325).</text>
</comment>
<comment type="domain">
<molecule>Isoform 10</molecule>
<text evidence="55">The C-terminal region contains a Cajal body localization signal at positions 490 through 506 (PubMed:24204304).</text>
</comment>
<comment type="PTM">
<text evidence="9 28">Phosphorylated (PubMed:14532325). Phosphorylated on several serine residues. Phosphorylation at Ser-500 is required for phosphorylation of other nearby serine residues. Phosphorylation has no effect on the binding of individual mRNA species, but may affect the association with polyribosome. Unphosphorylated FMR1 is associated with actively translating polyribosome, whereas a fraction of phosphorylated FMR1 is associated with apparently stalled polyribosome. Dephosphorylation by an activated phosphatase may release the FMR1-mediated translational repression and allow synthesis of a locally required protein at snypases (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="9">Monoubiquitinated. Polyubiquitinated. Ubiquitinated and targeted for proteasomal degradation after activation of metabotropic glutamate receptor (mGluR).</text>
</comment>
<comment type="PTM">
<text evidence="9 37 38">Monomethylated and asymmetrically dimethylated at four arginine residues of the arginine-glycine-glycine box. Methylation disrupts the binding of FMRP to RNAs through its RGG box (By similarity). Methylation is necessary for heterodimerization with FXR1, association with polyribosomes, recruitment into stress granules and translation of FMR1 target mRNAs (PubMed:16636078). Methylated by PRMT1, PRMT3 and PRMT4, in vitro (PubMed:16922515).</text>
</comment>
<comment type="PTM">
<molecule>Isoform 10</molecule>
<text evidence="55">Undergoes proteolytic cleavage; may be specifically cleaved by calpain-1/CAPN1 in cajal bodies (PubMed:24204304).</text>
</comment>
<comment type="disease" evidence="13 15 31 33 41 42 46 53 55 56 57 59 61 65 66 69 70 71 77">
<disease id="DI-01625">
<name>Fragile X syndrome</name>
<acronym>FXS</acronym>
<description>An X-linked dominant disease characterized by moderate to severe mental retardation, macroorchidism (enlargement of the testicles), large ears, prominent jaw, and high-pitched, jocular speech. The defect in most patients results from an amplification of a CGG repeat region in the FMR1 gene and abnormal methylation.</description>
<dbReference type="MIM" id="300624"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="16">
<disease id="DI-01626">
<name>Fragile X tremor/ataxia syndrome</name>
<acronym>FXTAS</acronym>
<description>In FXTAS, the expanded repeats range in size from 55 to 200 repeats and are referred to as 'premutations'. Full repeat expansions with greater than 200 repeats results in fragile X mental retardation syndrome [MIM:300624]. Carriers of the premutation typically do not show the full fragile X syndrome phenotype, but comprise a subgroup that may have some physical features of fragile X syndrome or mild cognitive and emotional problems.</description>
<dbReference type="MIM" id="300623"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="78">
<disease id="DI-02518">
<name>Premature ovarian failure 1</name>
<acronym>POF1</acronym>
<description>An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol.</description>
<dbReference type="MIM" id="311360"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The mechanism of the severe phenotype in the Asn-304 patient lies in the sequestration of bound mRNAs in nontranslatable mRNP particles. In the absence of FMRP, these same mRNAs may be partially translated via alternate mRNPs, although perhaps abnormally localized or regulated, resulting in typical fragile X syndrome. Asn-304 mutation maps to a position within the second KH domain of FMRP that is critical for stabilizing sequence-specific RNA-protein interactions. Asn-304 mutation abrogates the association of the FMRP KH 2 domain with its target, kissing complex RNA.</text>
</comment>
<comment type="similarity">
<text evidence="84">Belongs to the FMR1 family.</text>
</comment>
<comment type="sequence caution" evidence="84">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA52458" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="84">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAA62466" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="84">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAA62467" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18828.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18829.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18830.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18831.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18832.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L29074">
<property type="protein sequence ID" value="AAB18833.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KJ534836">
<property type="protein sequence ID" value="AHW56476.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61294.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61296.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61298.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61301.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61302.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471171">
<property type="protein sequence ID" value="EAW61303.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC086957">
<property type="protein sequence ID" value="AAH86957.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M67468">
<property type="protein sequence ID" value="AAA52458.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X69962">
<property type="protein sequence ID" value="CAA49586.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S65791">
<property type="protein sequence ID" value="AAB28395.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L19476">
<property type="protein sequence ID" value="AAA62452.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19477">
<property type="protein sequence ID" value="AAA62453.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19478">
<property type="protein sequence ID" value="AAA62454.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19479">
<property type="protein sequence ID" value="AAA62455.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19480">
<property type="protein sequence ID" value="AAA62456.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19481">
<property type="protein sequence ID" value="AAA62457.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19482">
<property type="protein sequence ID" value="AAA62458.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19483">
<property type="protein sequence ID" value="AAA62459.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19484">
<property type="protein sequence ID" value="AAA62460.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19485">
<property type="protein sequence ID" value="AAA62461.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19486">
<property type="protein sequence ID" value="AAA62462.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19487">
<property type="protein sequence ID" value="AAA62463.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19488">
<property type="protein sequence ID" value="AAA62464.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19489">
<property type="protein sequence ID" value="AAA62465.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19490">
<property type="protein sequence ID" value="AAA62466.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19491">
<property type="protein sequence ID" value="AAA62467.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19492">
<property type="protein sequence ID" value="AAA62468.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19493">
<property type="protein sequence ID" value="AAA62469.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76590">
<property type="protein sequence ID" value="AAD14228.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14682.1">
<molecule id="Q06787-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55518.1">
<molecule id="Q06787-10"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55519.1">
<molecule id="Q06787-9"/>
</dbReference>
<dbReference type="CCDS" id="CCDS76039.1">
<molecule id="Q06787-8"/>
</dbReference>
<dbReference type="PIR" id="I68614">
<property type="entry name" value="I68614"/>
</dbReference>
<dbReference type="PIR" id="S45243">
<property type="entry name" value="A40724"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001172004.1">
<molecule id="Q06787-10"/>
<property type="nucleotide sequence ID" value="NM_001185075.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001172005.1">
<molecule id="Q06787-9"/>
<property type="nucleotide sequence ID" value="NM_001185076.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001172010.1">
<molecule id="Q06787-11"/>
<property type="nucleotide sequence ID" value="NM_001185081.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001172011.1">
<molecule id="Q06787-8"/>
<property type="nucleotide sequence ID" value="NM_001185082.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002015.1">
<molecule id="Q06787-1"/>
<property type="nucleotide sequence ID" value="NM_002024.5"/>
</dbReference>
<dbReference type="PDB" id="2BKD">
<property type="method" value="NMR"/>
<property type="chains" value="N=1-134"/>
</dbReference>
<dbReference type="PDB" id="2FMR">
<property type="method" value="NMR"/>
<property type="chains" value="A=216-280"/>
</dbReference>
<dbReference type="PDB" id="2LA5">
<property type="method" value="NMR"/>
<property type="chains" value="B=527-541"/>
</dbReference>
<dbReference type="PDB" id="2QND">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=216-425"/>
</dbReference>
<dbReference type="PDB" id="4OVA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D=1-209"/>
</dbReference>
<dbReference type="PDB" id="4QVZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=1-213"/>
</dbReference>
<dbReference type="PDB" id="4QW2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B=1-213"/>
</dbReference>
<dbReference type="PDB" id="5DE5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B/D=528-544"/>
</dbReference>
<dbReference type="PDB" id="5DE8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=528-544"/>
</dbReference>
<dbReference type="PDB" id="5DEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B/D=528-544"/>
</dbReference>
<dbReference type="PDB" id="5UWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="D=423-437"/>
</dbReference>
<dbReference type="PDB" id="5UWO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="D=422-438"/>
</dbReference>
<dbReference type="PDBsum" id="2BKD"/>
<dbReference type="PDBsum" id="2FMR"/>
<dbReference type="PDBsum" id="2LA5"/>
<dbReference type="PDBsum" id="2QND"/>
<dbReference type="PDBsum" id="4OVA"/>
<dbReference type="PDBsum" id="4QVZ"/>
<dbReference type="PDBsum" id="4QW2"/>
<dbReference type="PDBsum" id="5DE5"/>
<dbReference type="PDBsum" id="5DE8"/>
<dbReference type="PDBsum" id="5DEA"/>
<dbReference type="PDBsum" id="5UWJ"/>
<dbReference type="PDBsum" id="5UWO"/>
<dbReference type="SMR" id="Q06787"/>
<dbReference type="BioGRID" id="108619">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="DIP" id="DIP-29509N"/>
<dbReference type="IntAct" id="Q06787">
<property type="interactions" value="294"/>
</dbReference>
<dbReference type="MINT" id="Q06787"/>
<dbReference type="STRING" id="9606.ENSP00000359506"/>
<dbReference type="iPTMnet" id="Q06787"/>
<dbReference type="MetOSite" id="Q06787"/>
<dbReference type="PhosphoSitePlus" id="Q06787"/>
<dbReference type="BioMuta" id="FMR1"/>
<dbReference type="DMDM" id="544328"/>
<dbReference type="EPD" id="Q06787"/>
<dbReference type="jPOST" id="Q06787"/>
<dbReference type="MassIVE" id="Q06787"/>
<dbReference type="MaxQB" id="Q06787"/>
<dbReference type="PaxDb" id="Q06787"/>
<dbReference type="PeptideAtlas" id="Q06787"/>
<dbReference type="PRIDE" id="Q06787"/>
<dbReference type="ProteomicsDB" id="34152"/>
<dbReference type="ProteomicsDB" id="58477">
<molecule id="Q06787-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58478">
<molecule id="Q06787-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58479">
<molecule id="Q06787-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58480">
<molecule id="Q06787-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58481">
<molecule id="Q06787-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58482">
<molecule id="Q06787-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58483">
<molecule id="Q06787-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58484">
<molecule id="Q06787-8"/>
</dbReference>
<dbReference type="Antibodypedia" id="3246">
<property type="antibodies" value="712 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000218200">
<molecule id="Q06787-9"/>
<property type="protein sequence ID" value="ENSP00000218200"/>
<property type="gene ID" value="ENSG00000102081"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000370470">
<molecule id="Q06787-6"/>
<property type="protein sequence ID" value="ENSP00000359501"/>
<property type="gene ID" value="ENSG00000102081"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000370471">
<molecule id="Q06787-10"/>
<property type="protein sequence ID" value="ENSP00000359502"/>
<property type="gene ID" value="ENSG00000102081"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000370475">
<molecule id="Q06787-1"/>
<property type="protein sequence ID" value="ENSP00000359506"/>
<property type="gene ID" value="ENSG00000102081"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000440235">
<molecule id="Q06787-8"/>
<property type="protein sequence ID" value="ENSP00000413764"/>
<property type="gene ID" value="ENSG00000102081"/>
</dbReference>
<dbReference type="GeneID" id="2332"/>
<dbReference type="KEGG" id="hsa:2332"/>
<dbReference type="UCSC" id="uc004fck.5">
<molecule id="Q06787-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2332"/>
<dbReference type="DisGeNET" id="2332"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000102081.13"/>
<dbReference type="GeneCards" id="FMR1"/>
<dbReference type="GeneReviews" id="FMR1"/>
<dbReference type="HGNC" id="HGNC:3775">
<property type="gene designation" value="FMR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000102081">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="FMR1"/>
<dbReference type="MIM" id="300623">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300624">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="309550">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="311360">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616034">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06787"/>
<dbReference type="OpenTargets" id="ENSG00000102081"/>
<dbReference type="Orphanet" id="908">
<property type="disease" value="Fragile X syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="93256">
<property type="disease" value="Fragile X-associated tremor/ataxia syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="619">
<property type="disease" value="NON RARE IN EUROPE: Primary ovarian failure"/>
</dbReference>
<dbReference type="Orphanet" id="449291">
<property type="disease" value="Symptomatic form of fragile X syndrome in female carrier"/>
</dbReference>
<dbReference type="Orphanet" id="261483">
<property type="disease" value="Xq27.3q28 duplication syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28191"/>
<dbReference type="eggNOG" id="ENOG502QPKJ">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183189"/>
<dbReference type="HOGENOM" id="CLU_020699_4_0_1"/>
<dbReference type="InParanoid" id="Q06787"/>
<dbReference type="KO" id="K15516"/>
<dbReference type="OMA" id="TNERENC"/>
<dbReference type="OrthoDB" id="374073at2759"/>
<dbReference type="PhylomeDB" id="Q06787"/>
<dbReference type="TreeFam" id="TF105427"/>
<dbReference type="PathwayCommons" id="Q06787"/>
<dbReference type="SIGNOR" id="Q06787"/>
<dbReference type="BioGRID-ORCS" id="2332">
<property type="hits" value="6 hits in 503 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FMR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q06787"/>
<dbReference type="GeneWiki" id="FMR1"/>
<dbReference type="GenomeRNAi" id="2332"/>
<dbReference type="Pharos" id="Q06787">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q06787"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q06787">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000102081">
<property type="expression patterns" value="Expressed in female gonad and 248 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q06787">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06787">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043679">
<property type="term" value="C:axon terminus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015030">
<property type="term" value="C:Cajal body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042995">
<property type="term" value="C:cell projection"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010369">
<property type="term" value="C:chromocenter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000775">
<property type="term" value="C:chromosome, centromeric region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010494">
<property type="term" value="C:cytoplasmic stress granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902737">
<property type="term" value="C:dendritic filopodium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044326">
<property type="term" value="C:dendritic spine neck"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019897">
<property type="term" value="C:extrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032433">
<property type="term" value="C:filopodium tip"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097386">
<property type="term" value="C:glial cell projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990812">
<property type="term" value="C:growth cone filopodium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990124">
<property type="term" value="C:messenger ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005845">
<property type="term" value="C:mRNA cap binding complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071598">
<property type="term" value="C:neuronal ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043204">
<property type="term" value="C:perikaryon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005844">
<property type="term" value="C:polysome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098793">
<property type="term" value="C:presynapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042734">
<property type="term" value="C:presynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035770">
<property type="term" value="C:ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019034">
<property type="term" value="C:viral replication complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070840">
<property type="term" value="F:dynein complex binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002151">
<property type="term" value="F:G-quadruplex RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035064">
<property type="term" value="F:methylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035198">
<property type="term" value="F:miRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003730">
<property type="term" value="F:mRNA 3'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048027">
<property type="term" value="F:mRNA 5'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034046">
<property type="term" value="F:poly(G) binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008266">
<property type="term" value="F:poly(U) RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043022">
<property type="term" value="F:ribosome binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035613">
<property type="term" value="F:RNA stem-loop binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033592">
<property type="term" value="F:RNA strand annealing activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990825">
<property type="term" value="F:sequence-specific mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035197">
<property type="term" value="F:siRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031369">
<property type="term" value="F:translation initiation factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045182">
<property type="term" value="F:translation regulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030371">
<property type="term" value="F:translation repressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072711">
<property type="term" value="P:cellular response to hydroxyurea"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098586">
<property type="term" value="P:cellular response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031047">
<property type="term" value="P:gene silencing by RNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007215">
<property type="term" value="P:glutamate receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044830">
<property type="term" value="P:modulation by host of viral RNA genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051028">
<property type="term" value="P:mRNA transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000766">
<property type="term" value="P:negative regulation of cytoplasmic translation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900453">
<property type="term" value="P:negative regulation of long-term synaptic depression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902373">
<property type="term" value="P:negative regulation of mRNA catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:2000301">
<property type="term" value="P:negative regulation of synaptic vesicle exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045947">
<property type="term" value="P:negative regulation of translational initiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901386">
<property type="term" value="P:negative regulation of voltage-gated calcium channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060999">
<property type="term" value="P:positive regulation of dendritic spine development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051491">
<property type="term" value="P:positive regulation of filopodium assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000637">
<property type="term" value="P:positive regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033129">
<property type="term" value="P:positive regulation of histone phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901254">
<property type="term" value="P:positive regulation of intracellular transport of viral material"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902416">
<property type="term" value="P:positive regulation of mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901800">
<property type="term" value="P:positive regulation of proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002092">
<property type="term" value="P:positive regulation of receptor internalization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001022">
<property type="term" value="P:positive regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060998">
<property type="term" value="P:regulation of dendritic spine development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051489">
<property type="term" value="P:regulation of filopodium assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060964">
<property type="term" value="P:regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098908">
<property type="term" value="P:regulation of neuronal action potential"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046928">
<property type="term" value="P:regulation of neurotransmitter secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="DisProt" id="DP00134"/>
<dbReference type="Gene3D" id="3.30.1370.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008395">
<property type="entry name" value="Agenet-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR040148">
<property type="entry name" value="FMR1"/>
</dbReference>
<dbReference type="InterPro" id="IPR040472">
<property type="entry name" value="FMRP_KH0"/>
</dbReference>
<dbReference type="InterPro" id="IPR032196">
<property type="entry name" value="FXMR_C2"/>
</dbReference>
<dbReference type="InterPro" id="IPR022034">
<property type="entry name" value="FXMRP1_C_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR004087">
<property type="entry name" value="KH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004088">
<property type="entry name" value="KH_dom_type_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036612">
<property type="entry name" value="KH_dom_type_1_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR041560">
<property type="entry name" value="Tudor_FRX1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10603">
<property type="entry name" value="PTHR10603"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05641">
<property type="entry name" value="Agenet"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16098">
<property type="entry name" value="FXMR_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12235">
<property type="entry name" value="FXMRP1_C_core"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00013">
<property type="entry name" value="KH_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF17904">
<property type="entry name" value="KH_9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18336">
<property type="entry name" value="Tudor_FRX1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00322">
<property type="entry name" value="KH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54791">
<property type="entry name" value="SSF54791"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51641">
<property type="entry name" value="AGENET_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50084">
<property type="entry name" value="KH_TYPE_1"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0509">mRNA transport</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-1066">Premature ovarian failure</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0687">Ribonucleoprotein</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0943">RNA-mediated gene silencing</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0771">Synaptosome</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Synaptic functional regulator FMR1" id="PRO_0000050102">
<location>
<begin position="1"/>
<end position="632"/>
</location>
</feature>
<feature type="domain" description="Agenet-like 1" evidence="12">
<location>
<begin position="4"/>
<end position="50"/>
</location>
</feature>
<feature type="domain" description="Agenet-like 2" evidence="12">
<location>
<begin position="63"/>
<end position="115"/>
</location>
</feature>
<feature type="domain" description="KH 1" evidence="11">
<location>
<begin position="222"/>
<end position="251"/>
</location>
</feature>
<feature type="domain" description="KH 2" evidence="11">
<location>
<begin position="285"/>
<end position="314"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization" evidence="9">
<location>
<begin position="1"/>
<end position="184"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with CYFIP1, CYFIP2, FXR1 and FXR2" evidence="9 28 74">
<location>
<begin position="172"/>
<end position="211"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear export" evidence="47 75">
<location>
<begin position="397"/>
<end position="491"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RANBP9" evidence="32">
<location>
<begin position="419"/>
<end position="632"/>
</location>
</feature>
<feature type="region of interest" description="RNA-binding RGG-box">
<location>
<begin position="534"/>
<end position="548"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="9">
<location>
<begin position="424"/>
<end position="443"/>
</location>
</feature>
<feature type="short sequence motif" description="Nucleolar localization signal 1" evidence="58">
<location>
<begin position="527"/>
<end position="534"/>
</location>
</feature>
<feature type="short sequence motif" description="Nucleolar localization signal 2" evidence="58">
<location>
<begin position="613"/>
<end position="617"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="337"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="463"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="9">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 21">
<location>
<position position="500"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="9">
<location>
<position position="534"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="9">
<location>
<position position="534"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="9">
<location>
<position position="539"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="9">
<location>
<position position="539"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="9">
<location>
<position position="544"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="38">
<location>
<position position="544"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="9">
<location>
<position position="544"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="9">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="9">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="620"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1, isoform 8, isoform 9 and isoform 11." id="VSP_002823" evidence="79 81 82">
<location>
<begin position="376"/>
<end position="396"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10 and isoform 11." id="VSP_058423" evidence="82">
<original>EVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP</original>
<variation>LQQRKRGRASCAEETDGGVEGEEEDKEEEDVEEASKETTITPEQIIVHVIQERLKEEQQMDPFRSELTAIMKGVSTLKHYRIPPVKVVGCARVKIVTRRKRSQTAWMVSNHS</variation>
<location>
<begin position="426"/>
<end position="632"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 5 and isoform 8." id="VSP_002825" evidence="79">
<location>
<begin position="491"/>
<end position="515"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_002824" evidence="84">
<location>
<begin position="491"/>
<end position="502"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1, isoform 3, isoform 5 and isoform 7." id="VSP_002826" evidence="84">
<location>
<begin position="580"/>
<end position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In FXS; rare variant found in a developmentally delayed male; inhibits nucleosome binding; reduces interaction with KCNMB4; inhibits presynaptic action potential (AP) broadening; does not alter postsynaptic RNA-binding and polyribosome association; dbSNP:rs200163413." id="VAR_064507" evidence="51 59 61">
<original>R</original>
<variation>Q</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs29281." id="VAR_029278">
<original>A</original>
<variation>S</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In FXS; reduces association with polyribosome; reduces RNA-binding; dbSNP:rs1569545763." id="VAR_075977" evidence="56">
<original>G</original>
<variation>E</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In FXS; alters protein folding and stability; increases nucleocytoplasmic shuttling; reduces localization in Cajal bodies; reduces the association with cytoplasmic granules; reduces association with polyribosome; reduces RNA-binding; attenuates mRNA translation repression; impairs homooligomerization; reduces interaction with TDRD3; reduces interaction with viral influenza A nucleoprotein (NP); does not inhibit interaction with SMN1, FXR1 and FXR2; dbSNP:rs121434622." id="VAR_005234" evidence="13 15 31 33 41 42 46 53 55 57 65 69 71 77">
<original>I</original>
<variation>N</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs782651077." id="VAR_005235" evidence="76">
<original>R</original>
<variation>H</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to nucleosome." evidence="59">
<original>T</original>
<variation>A</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to nucleosome." evidence="59">
<original>Y</original>
<variation>L</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters the structural integrity of the N-terminus and leads to aggregation." evidence="34">
<original>TF</original>
<variation>AA</variation>
<location>
<begin position="125"/>
<end position="126"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation. Does not affect interaction with MCRS1. Does not affect localization to cytoplasmic granules. Does not affect association with polyribosome." evidence="21 28 35">
<original>S</original>
<variation>A</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect RNA-binding to G-quadruplex structure." evidence="62">
<original>S</original>
<variation>D</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces nucleolar localization. Strongly reduces nucleolar localization; when associated with 613-E--E-617." evidence="58">
<original>RRGDGRRR</original>
<variation>EEGDGEEE</variation>
<location>
<begin position="527"/>
<end position="534"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces arginine methylation by 80%." evidence="38">
<original>R</original>
<variation>K</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced methylation." evidence="38">
<original>R</original>
<variation>K</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces nucleolar localization. Strongly reduces nucleolar localization; when associated with 527-E--E-534." evidence="58">
<original>QKKEK</original>
<variation>EEEEE</variation>
<location>
<begin position="613"/>
<end position="617"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52458." ref="1" evidence="84">
<location>
<begin position="294"/>
<end position="295"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="5"/>
<end position="9"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="15"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="25"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="64"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="71"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="78"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="91"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="100"/>
<end position="103"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="104"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="127"/>
<end position="132"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="144"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="148"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="157"/>
<end position="162"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="167"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="177"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="220"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="230"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="239"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="250"/>
<end position="256"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="257"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="261"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="269"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="281"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="293"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="302"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="314"/>
<end position="321"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="398"/>
<end position="406"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="407"/>
<end position="422"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="432"/>
<end position="434"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="535"/>
<end position="538"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LA5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2QND"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OVA"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4QW2"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UWJ"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35922"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80WE1"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00117"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00973"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10196376"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10556305"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11157796"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11445641"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11532944"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719188"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719189"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12417734"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446764"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12575950"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12594214"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12837692"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12927206"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12950170"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14508492"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532325"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14703574"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15282548"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15380484"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15381419"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15805463"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407062"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16571602"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16631377"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16636078"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16922515"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17057366"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17417632"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17850748"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18093976"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18579868"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18632687"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18653529"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18664458"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18936162"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19097999"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19166269"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20512134"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20799337"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21771594"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23235829"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23891804"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24204304"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24448548"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24514761"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24658146"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24813610"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25464849"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25561520"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25692235"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27509095"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7489725"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633450"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7688265"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7692601"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7781595"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8156595"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8401578"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8490650"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8504300"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8515814"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8668200"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8789445"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9375856"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9659908"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9719368"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1710175"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="24722188"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8789445"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9659908"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000305"/>
<evidence key="85" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:3775"/>
</source>
</evidence>
<sequence length="632" mass="71174" checksum="F853D6C82E3489B9" modified="1994-06-01" version="1">MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGANIQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKNGKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKENSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYHLNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

